Developer docs
API playgroundTry for free, no card

Search company profiles

Slade Pharmacy

Full company profile

uuid002p4vn

Namestring
Slade Pharmacy
Legal namestring
Slade Pharmacy Management Pty Ltd
Company typeenum
Private
Founded yearint
1965
Descriptiontext

Slade Pharmacy is an Australian hospital pharmacy services provider founded in 1965 by Graham Slade, now operating as part of Icon Group under the leadership of CEO Russell Hill (appointed 2025). The company operates more than 70 pharmacy sites physically embedded within private hospitals and oncology centres across Victoria, Queensland, Tasmania, New South Wales, South Australia, and the Australian Capital Territory. Its core offering consists of hospital and oncology pharmacy services — inpatient dispensing, discharge medication, clinical pharmacy ward services, imprest management, chemotherapy preparation, and hospital accreditation support — delivered as contracted managed services to private hospital partners, including Epworth HealthCare (50-year partnership extended through 2031), St Vincent's Private Hospital, The Wesley Hospital, and St Andrew's War Memorial Hospital.

The company's technology stack centres on hospital pharmacy and oncology dispensing systems supplemented by a proprietary digital medication ordering tool called ChartFlow, which is deployed across all Epworth hospital sites and used by over 950 nurses for real-time order transmission, prioritised work queues, and live dispensary performance monitoring. Slade also operates four TGA-licensed compounding facilities (under the Slade Health brand) in Richmond (VIC) and New Town (TAS), producing sterile and non-sterile compounded medications for Australia-wide delivery, including IVF medications, hormone preparations, eye drops, and veterinary products. The company holds AHPRA pharmacist registrations, PIC/S PE-010 compliance certification, and PBS-approved pharmacy network status, with an internal Quality and Medication Safety Unit (QMSU) providing clinical governance frameworks.

Revenue is generated through multiple streams: PBS and non-PBS dispensing (transaction fees), contracted hospital pharmacy management services (managed services), compounded medication sales (transaction fees with Australia-wide delivery), retail pharmacy products (including skincare, medical equipment hire, and compression garments), and specialist services such as IVF pharmacy and botulinum toxin dispensing. The go-to-market is enterprise field sales — pharmacy services are contracted to private hospital groups, with patient referrals flowing from hospital admissions, specialist oncology clinics, IVF fertility clinics, and specialist physician practices. SladePLUS loyalty program (5% back on eligible items) supports consumer retail. The company also operates the Epic Pharmacy sub-brand and has expanded into New Zealand via Slade Health NZ, with remote community dispensing through the S100 RAAHS Program in partnership with the Royal Flying Doctor Service.

Short descriptiontext

Slade Pharmacy operates 70+ hospital-embedded pharmacy sites across Australia, providing inpatient dispensing, oncology pharmacy, sterile compounding, and specialist services (IVF, botulinum toxin, clinical trials) to private hospitals and patients as part of Icon Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersMount Waverley, Australia
HQ citystring
Mount Waverley
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices15 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hospital pharmacy services, oncology pharmacy dispensing, compounded medications, IVF pharmacy services, sterile pharmaceutical compounding
Industry2 codes
PRIMARYHLAFALAB
Hospital & Health-System Pharmacies (Inpatient/Outpatient)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFALAC
Specialty Pharmacies (Complex/High-Cost Therapies)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code1 code
  • Pharmacies and Drug Retailers45611
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Hospital Pharmacy Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model7 records
1PBS Dispensing
TypeTransaction Fee
Description

Pharmaceutical Benefits Scheme (PBS) dispensing to hospital inpatients and discharge patients, subsidised by the Australian Government.

sladepharmacy.com.au
2Non-PBS Dispensing
TypeTransaction Fee
Description

Dispensing of medications not listed on the PBS, charged directly to patients.

sladepharmacy.com.au
3Compounded Medications
TypeTransaction Fee
Description

Custom-made medications prepared in Richmond (VIC) and New Town (TAS) compounding pharmacies, sold to patients via delivery Australia-wide or in-store collection. Delivered as sterile and non-sterile preparations.

sladepharmacy.com.au
4Hospital Pharmacy Services
TypeManaged Services
Description

Contracted pharmacy management services to private hospitals including imprest management, inpatient dispensing, clinical pharmacy services, and accreditation support.

sladepharmacy.com.au
5Retail and Consumer Products
TypeHardware Sales
Description

Sale of beauty, skincare, fragrances, medical equipment hire, compression garments, nutritionals, and over-the-counter pharmacy items at retail pharmacy locations.

sladepharmacy.com.au
6IVF Medication Services
TypeTransaction Fee
Description

Dispensing of IVF medications and specialist pharmacist support through partnerships with fertility clinics, with collection from selected Victorian pharmacy locations.

sladepharmacy.com.au
7Botulinum Toxin Dispensing
TypeTransaction Fee
Description

Approved botulinum toxin dispenser providing seamless supply to clinics nationwide, managing PBS claim subsidy and patient co-payments.

sladepharmacy.com.au
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Pricing details1 tier
1SladePLUS Loyalty — earn 5% back on Eligible Items
ModelOtherBilling cadenceMonthly
Notes

1 SladePLUS Cash per $20 spent. Welcome $10 voucher within 48 hours. Birthday $10 voucher. SladePLUS Cash expires 24 months after being earned. Prescription items, baby formula, and gift cards are excluded from earning.

sladepharmacy.com.au
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1Epic Pharmacy
Description

Pharmacy brand under the Slade/Icon Group portfolio serving hospital and specialist settings.

sladepharmacy.com.au
Core offering1 text field

Slade Pharmacy operates more than 70 pharmacy sites embedded within private hospitals and oncology centres across Australia, providing inpatient and discharge medication dispensing, clinical pharmacy services, chemotherapy preparation, compounded medications (sterile and non-sterile), IVF pharmacy support, and botulinum toxin dispensing. Services are contracted to hospital partners (including a 50-year Epworth HealthCare partnership extended to 2031) and supported by the proprietary ChartFlow digital medication ordering tool. The company also operates a retail pharmacy network with the SladePLUS loyalty program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • ChartFlow used by over 950 nurses across all Epworth sites, enhancing safety and workflow efficiency through real-time order transmission.
Product overview1 text field

Slade Pharmacy operates as a network of hospital, oncology, and specialist pharmacies across Australia, offering a comprehensive suite of pharmacy services. The core offering consists of hospital and oncology pharmacy services (inpatient dispensing, discharge medication, chemotherapy preparation) supported by specialist services including compounded medications (sterile and non-sterile), IVF pharmacy services, and botulinum toxin dispensing. Additional services encompass clinical trial support, governance and education programs, and a proprietary digital medication tool called ChartFlow. The network also includes retail pharmacy operations with health advice services (cancer treatment support, diabetes care, compression garments, nutritionals, recovery and mobility aids), and the SladePLUS loyalty program for customer rewards.

Product and service3 records
1Hospital & Oncology Pharmacy Services
Categorycore service
Description

Comprehensive pharmacy services delivered within hospital and oncology settings, including inpatient dispensing, discharge medication, clinical pharmacy services, chemotherapy preparation, medication counselling, and hospital accreditation support for private hospital partners across Australia.

2Compounded Medications
Categoryspecialist service
Description

Custom-made medications prepared in TGA-licensed sterile and non-sterile compounding facilities in Richmond (VIC) and New Town (TAS) for patients with specific dosage, formulation or ingredient-sensitivity needs. Includes creams, oral capsules, hormone preparations, eye drops, erectile dysfunction medications, IVF medications, and veterinary products, delivered Australia-wide or collected from selected locations.

3IVF Pharmacy Services
Categoryspecialist service
Description

Pharmacy services supporting IVF patients including dispensing of IVF medications, IVF device supply, training on device use and injection technique, counselling, and compounding of customised IVF formulations. Delivered through partnerships with leading fertility clinics, with collection from selected Victorian pharmacy locations.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-12
Description

Slade Pharmacy and Epworth HealthCare have maintained a 50-year partnership (originally established with Graham Slade in 1981) extended through a long-term contract renewal to 2031. Slade provides pharmacy services across all Epworth sites, including deployment of ChartFlow digital medication ordering tool used by 950+ nurses. The renewal reflects Epworth's trust in Slade's innovation, clinical excellence, and patient-centred care.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-10
Description

Slade Pharmacy Port Augusta partners with the Royal Flying Doctor Service through the S100 Remote Area Aboriginal Health Services (RAAHS) Program to deliver essential medicines to six remote South Australian communities each month. Pharmacists travel across remote regions to provide tailored medication management and culturally safe care to First Nations patients.

3S100 Remote Area Aboriginal Health Services (RAAHS) Program
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-10
Description

Slade Pharmacy participates in the S100 RAAHS Program at its Port Augusta location, working in close partnership with Aboriginal Health Practitioners to deliver culturally safe medication management to First Nations communities on the traditional lands of the Barngarla, Nukunu, and Adnyamathanha peoples.

sladepharmacy.com.au
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Australia's largest private hospital operator and a logical prospective customer for Slade's hospital pharmacy services. Comparable as a hospital counterpart that either contracts Slade or competes indirectly for pharmacy management scope.

TypeBroad incumbent
Description

Global hospital pharmacy and sterile compounding operator with extensive oncology injectable manufacturing. Comparable to Slade Health's sterile compounding capabilities and hospital-channel distribution at global scale.

TypeOthers
Description

Icon Group's medical oncology division operating cancer centres across Australia and Asia. Directly related as a sister entity and primary referral source for Slade's oncology dispensing and compounding services.

TypeBroad incumbent
Description

US healthcare services giant with a specialty pharmacy solutions arm serving hospitals and oncology centres. Comparable as a broad incumbent offering hospital and specialty pharmacy services at much larger scale.

TypeBroad incumbent
Description

Wesfarmers-owned pharmaceutical distributor and retail pharmacy operator (Priceline, Soul Pattinson). Comparable to Slade's community/retail pharmacy and wholesale distribution activities, though primarily retail-focused rather than hospital-embedded.

TypeDirect peer
Description

Sister brand within Icon Group providing hospital and specialty pharmacy services in Western Australia and other states. Operates a near-identical embedded hospital pharmacy model with compounding and oncology services.

TypeDirect peer
Description

UK-based pharmaceutical compounder and clinical homecare provider acquired by Icon Group. Comparable to Slade Health's compounding and clinical pharmacy operations, with international reach into NHS-funded services.

8GenesisCare
TypeBroad incumbent
Description

Large Australian oncology and cardiology provider with embedded pharmacy operations. Comparable as a customer/partner for Slade's oncology dispensing and as a broad incumbent in cancer care delivery where Slade supplies compounding and dispensing services.

TypeDirect peer
Description

Australian hospital pharmacy operator embedded in private and public hospitals. Directly comparable to Slade's model of providing inpatient dispensing, discharge medication, and clinical pharmacy services to hospital partners across Australia.

10McKesson (US Oncology / RxOwnership)
TypeBroad incumbent
Description

Global pharmaceutical distributor and pharmacy services operator with US Oncology Network. Comparable to Slade's oncology dispensing, hospital supply, and pharmacy management services, though at vastly greater scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Slade Pharmacy

Hospital Pharmacy Servicessladepharmacy.com.au

Slade Pharmacy operates 70+ hospital-embedded pharmacy sites across Australia, providing inpatient dispensing, oncology pharmacy, sterile compounding, and specialist services (IVF, botulinum toxin, clinical trials) to private hospitals and patients as part of Icon Group.

What Slade Pharmacy does

Slade Pharmacy is an Australian hospital pharmacy services provider founded in 1965 by Graham Slade, now operating as part of Icon Group under the leadership of CEO Russell Hill (appointed 2025). The company operates more than 70 pharmacy sites physically embedded within private hospitals and oncology centres across Victoria, Queensland, Tasmania, New South Wales, South Australia, and the Australian Capital Territory. Its core offering consists of hospital and oncology pharmacy services — inpatient dispensing, discharge medication, clinical pharmacy ward services, imprest management, chemotherapy preparation, and hospital accreditation support — delivered as contracted managed services to private hospital partners, including Epworth HealthCare (50-year partnership extended through 2031), St Vincent's Private Hospital, The Wesley Hospital, and St Andrew's War Memorial Hospital.

The company's technology stack centres on hospital pharmacy and oncology dispensing systems supplemented by a proprietary digital medication ordering tool called ChartFlow, which is deployed across all Epworth hospital sites and used by over 950 nurses for real-time order transmission, prioritised work queues, and live dispensary performance monitoring. Slade also operates four TGA-licensed compounding facilities (under the Slade Health brand) in Richmond (VIC) and New Town (TAS), producing sterile and non-sterile compounded medications for Australia-wide delivery, including IVF medications, hormone preparations, eye drops, and veterinary products. The company holds AHPRA pharmacist registrations, PIC/S PE-010 compliance certification, and PBS-approved pharmacy network status, with an internal Quality and Medication Safety Unit (QMSU) providing clinical governance frameworks.

Revenue is generated through multiple streams: PBS and non-PBS dispensing (transaction fees), contracted hospital pharmacy management services (managed services), compounded medication sales (transaction fees with Australia-wide delivery), retail pharmacy products (including skincare, medical equipment hire, and compression garments), and specialist services such as IVF pharmacy and botulinum toxin dispensing. The go-to-market is enterprise field sales — pharmacy services are contracted to private hospital groups, with patient referrals flowing from hospital admissions, specialist oncology clinics, IVF fertility clinics, and specialist physician practices. SladePLUS loyalty program (5% back on eligible items) supports consumer retail. The company also operates the Epic Pharmacy sub-brand and has expanded into New Zealand via Slade Health NZ, with remote community dispensing through the S100 RAAHS Program in partnership with the Royal Flying Doctor Service.

Slade Pharmacy firmographics

Firmographics
Name
Slade Pharmacy
Legal name
Slade Pharmacy Management Pty Ltd
Website
https://sladepharmacy.com.au
Company type
Private
Founded year
1965
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Slade Pharmacy operates 70+ hospital-embedded pharmacy sites across Australia, providing inpatient dispensing, oncology pharmacy, sterile compounding, and specialist services (IVF, botulinum toxin, clinical trials) to private hospitals and patients as part of Icon Group.
Ownership category
akta.pro rank

Slade Pharmacy industry classification

Industry
Product category
Hospital Pharmacy Services
NAICS
Pharmacies and Drug Retailers (45611)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro industry
PRIMARYHLAFALAB
Hospital & Health-System Pharmacies (Inpatient/Outpatient)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFALAC
Specialty Pharmacies (Complex/High-Cost Therapies)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Hospital pharmacy services
  • Oncology pharmacy dispensing
  • Compounded medications
  • IVF pharmacy services
  • Sterile pharmaceutical compounding

Where Slade Pharmacy is headquartered

Location

Headquarters

HQ city
Mount Waverley
HQ country
Australia
HQ region
Oceania

Offices15 records

Markets served

Slade Pharmacy business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. PBS Dispensing: Pharmaceutical Benefits Scheme (PBS) dispensing to hospital inpatients and discharge patients, subsidised by the Australian Government.
  2. Non-PBS Dispensing: Dispensing of medications not listed on the PBS, charged directly to patients.
  3. Compounded Medications: Custom-made medications prepared in Richmond (VIC) and New Town (TAS) compounding pharmacies, sold to patients via delivery Australia-wide or in-store collection. Delivered as sterile and non-sterile preparations.
  4. Hospital Pharmacy Services: Contracted pharmacy management services to private hospitals including imprest management, inpatient dispensing, clinical pharmacy services, and accreditation support.
  5. Retail and Consumer Products: Sale of beauty, skincare, fragrances, medical equipment hire, compression garments, nutritionals, and over-the-counter pharmacy items at retail pharmacy locations.
  6. IVF Medication Services: Dispensing of IVF medications and specialist pharmacist support through partnerships with fertility clinics, with collection from selected Victorian pharmacy locations.
  7. Botulinum Toxin Dispensing: Approved botulinum toxin dispenser providing seamless supply to clinics nationwide, managing PBS claim subsidy and patient co-payments.

Pricing tiers

ModelBillingPrice
OtherMonthlySladePLUS Loyalty — earn 5% back on Eligible Items

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Slade Pharmacy product offering

Product offering

Core offering

Slade Pharmacy operates more than 70 pharmacy sites embedded within private hospitals and oncology centres across Australia, providing inpatient and discharge medication dispensing, clinical pharmacy services, chemotherapy preparation, compounded medications (sterile and non-sterile), IVF pharmacy support, and botulinum toxin dispensing. Services are contracted to hospital partners (including a 50-year Epworth HealthCare partnership extended to 2031) and supported by the proprietary ChartFlow digital medication ordering tool. The company also operates a retail pharmacy network with the SladePLUS loyalty program.

Product overview

Slade Pharmacy operates as a network of hospital, oncology, and specialist pharmacies across Australia, offering a comprehensive suite of pharmacy services. The core offering consists of hospital and oncology pharmacy services (inpatient dispensing, discharge medication, chemotherapy preparation) supported by specialist services including compounded medications (sterile and non-sterile), IVF pharmacy services, and botulinum toxin dispensing. Additional services encompass clinical trial support, governance and education programs, and a proprietary digital medication tool called ChartFlow. The network also includes retail pharmacy operations with health advice services (cancer treatment support, diabetes care, compression garments, nutritionals, recovery and mobility aids), and the SladePLUS loyalty program for customer rewards.

Differentiator

Problem solved

Functional benefit

Brands

  • Epic Pharmacy: Pharmacy brand under the Slade/Icon Group portfolio serving hospital and specialist settings.

Products and services

  • Hospital & Oncology Pharmacy Services Comprehensive pharmacy services delivered within hospital and oncology settings, including inpatient dispensing, discharge medication, clinical pharmacy services, chemotherapy preparation, medication counselling, and hospital accreditation support for private hospital partners across Australia.
  • Compounded Medications Custom-made medications prepared in TGA-licensed sterile and non-sterile compounding facilities in Richmond (VIC) and New Town (TAS) for patients with specific dosage, formulation or ingredient-sensitivity needs. Includes creams, oral capsules, hormone preparations, eye drops, erectile dysfunction medications, IVF medications, and veterinary products, delivered Australia-wide or collected from selected locations.
  • IVF Pharmacy Services Pharmacy services supporting IVF patients including dispensing of IVF medications, IVF device supply, training on device use and injection technique, counselling, and compounding of customised IVF formulations. Delivered through partnerships with leading fertility clinics, with collection from selected Victorian pharmacy locations.

Quantifiable outcome

  • ChartFlow used by over 950 nurses across all Epworth sites, enhancing safety and workflow efficiency through real-time order transmission.

Companies that use Slade Pharmacy

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Slade Pharmacy technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Slade Pharmacy partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Epworth HealthCarecoreStrategic or Co-development Partner · 12 January 2026Slade Pharmacy and Epworth HealthCare have maintained a 50-year partnership (originally established with Graham Slade in 1981) extended through a long-term contract renewal to 2031. Slade provides pharmacy services across all Epworth sites, including deployment of ChartFlow digital medication ordering tool used by 950+ nurses. The renewal reflects Epworth's trust in Slade's innovation, clinical excellence, and patient-centred care.
  • Royal Flying Doctor ServicecoreStrategic or Co-development Partner · 10 July 2025Slade Pharmacy Port Augusta partners with the Royal Flying Doctor Service through the S100 Remote Area Aboriginal Health Services (RAAHS) Program to deliver essential medicines to six remote South Australian communities each month. Pharmacists travel across remote regions to provide tailored medication management and culturally safe care to First Nations patients.
  • S100 Remote Area Aboriginal Health Services (RAAHS) ProgramcoreStrategic or Co-development Partner · 10 July 2025Slade Pharmacy participates in the S100 RAAHS Program at its Port Augusta location, working in close partnership with Aboriginal Health Practitioners to deliver culturally safe medication management to First Nations communities on the traditional lands of the Barngarla, Nukunu, and Adnyamathanha peoples.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Slade Pharmacy competitors and assessment

Company assessment

Others

  • Ramsay Health Care: Australia's largest private hospital operator and a logical prospective customer for Slade's hospital pharmacy services. Comparable as a hospital counterpart that either contracts Slade or competes indirectly for pharmacy management scope.
  • Icon Cancer Centre: Icon Group's medical oncology division operating cancer centres across Australia and Asia. Directly related as a sister entity and primary referral source for Slade's oncology dispensing and compounding services.

Broad incumbents

  • Fresenius Kabi: Global hospital pharmacy and sterile compounding operator with extensive oncology injectable manufacturing. Comparable to Slade Health's sterile compounding capabilities and hospital-channel distribution at global scale.
  • Cardinal Health (Specialty Pharmacy): US healthcare services giant with a specialty pharmacy solutions arm serving hospitals and oncology centres. Comparable as a broad incumbent offering hospital and specialty pharmacy services at much larger scale.
  • API (Australian Pharmaceutical Industries): Wesfarmers-owned pharmaceutical distributor and retail pharmacy operator (Priceline, Soul Pattinson). Comparable to Slade's community/retail pharmacy and wholesale distribution activities, though primarily retail-focused rather than hospital-embedded.
  • GenesisCare: Large Australian oncology and cardiology provider with embedded pharmacy operations. Comparable as a customer/partner for Slade's oncology dispensing and as a broad incumbent in cancer care delivery where Slade supplies compounding and dispensing services.
  • McKesson (US Oncology / RxOwnership): Global pharmaceutical distributor and pharmacy services operator with US Oncology Network. Comparable to Slade's oncology dispensing, hospital supply, and pharmacy management services, though at vastly greater scale.

Direct peers

  • Epic Pharmacy: Sister brand within Icon Group providing hospital and specialty pharmacy services in Western Australia and other states. Operates a near-identical embedded hospital pharmacy model with compounding and oncology services.
  • Pharmaxo Group: UK-based pharmaceutical compounder and clinical homecare provider acquired by Icon Group. Comparable to Slade Health's compounding and clinical pharmacy operations, with international reach into NHS-funded services.
  • HPS Pharmacy (Hospital Pharmacy Services): Australian hospital pharmacy operator embedded in private and public hospitals. Directly comparable to Slade's model of providing inpatient dispensing, discharge medication, and clinical pharmacy services to hospital partners across Australia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Slade Pharmacy social profiles

Digital presence

Slade Pharmacy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Slade Pharmacy leadership team

Management profile

Number of profiles

Profiles10 records

Slade Pharmacy subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Slade Pharmacy funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Slade Pharmacy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Slade Pharmacy

What does Slade Pharmacy do?

Slade Pharmacy operates more than 70 pharmacy sites embedded within private hospitals and oncology centres across Australia, providing inpatient and discharge medication dispensing, clinical pharmacy services, chemotherapy preparation, compounded medications (sterile and non-sterile), IVF pharmacy support, and botulinum toxin dispensing. Services are contracted to hospital partners (including a 50-year Epworth HealthCare partnership extended to 2031) and supported by the proprietary ChartFlow digital medication ordering tool. The company also operates a retail pharmacy network with the SladePLUS loyalty program.

Is Slade Pharmacy a public or private company?

Slade Pharmacy is a private company. It is classified as corporate owned and is currently operating.

When was Slade Pharmacy founded?

Slade Pharmacy was founded in 1965. It employs 1,001 to 5,000 people.

Where is Slade Pharmacy based?

Slade Pharmacy is headquartered in Mount Waverley, Australia, in the Oceania region.

How does Slade Pharmacy make money?

Seven revenue lines are on record. PBS Dispensing is the primary driver. The others are non-PBS Dispensing, compounded Medications, hospital Pharmacy Services, retail and Consumer Products, IVF Medication Services and botulinum Toxin Dispensing.

Who are Slade Pharmacy's main competitors?

Others on record are Ramsay Health Care and Icon Cancer Centre. Broad incumbents are Fresenius Kabi, Cardinal Health (Specialty Pharmacy), API (Australian Pharmaceutical Industries), GenesisCare and McKesson (US Oncology / RxOwnership). Direct peers are Epic Pharmacy, Pharmaxo Group and HPS Pharmacy (Hospital Pharmacy Services).

Does Slade Pharmacy have an API?

No public API is recorded for Slade Pharmacy.

What industry is Slade Pharmacy in?

Slade Pharmacy's product category is Hospital Pharmacy Services. Its primary akta.pro industry code is HLAFALAB, Hospital & Health-System Pharmacies (Inpatient/Outpatient), with a secondary code of HLAFALAC, Specialty Pharmacies (Complex/High-Cost Therapies). Its NAICS code is 45611 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales